117 related articles for article (PubMed ID: 29885441)
21. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
Yang L; Tang L; Dai F; Meng G; Yin R; Xu X; Yao W
Toxicology; 2017 Aug; 389():74-84. PubMed ID: 28743511
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model.
Koyanagi T; Noguchi K; Ootani A; Inagaki K; Robbins RC; Mochly-Rosen D
J Mol Cell Cardiol; 2007 Oct; 43(4):517-22. PubMed ID: 17655859
[TBL] [Abstract][Full Text] [Related]
23. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
24. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
25. RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: suppression by cilostazol.
Park SY; Lee SW; Lee WS; Rhim BY; Lee SJ; Kwon SM; Hong KW; Kim CD
Biochem Pharmacol; 2013 Nov; 86(9):1320-7. PubMed ID: 23973526
[TBL] [Abstract][Full Text] [Related]
26. Rho GDP dissociation inhibitor α silencing attenuates silicosis by inhibiting RhoA/Rho kinase signalling.
Wei Z; Xu H; Zhang Y; Yi X; Yang X; Chen Y; Mao N; Li S; Xu D; Li S; Zhang H; Li D; Zhang G; Zhang B; Jin F; Gao X; Cai W; Zhang L; Wang R; Yang F
Exp Cell Res; 2019 Jul; 380(2):131-140. PubMed ID: 31029634
[TBL] [Abstract][Full Text] [Related]
27. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
[TBL] [Abstract][Full Text] [Related]
28. RhoA/ROCK downregulates FPR2-mediated NADPH oxidase activation in mouse bone marrow granulocytes.
Filina JV; Gabdoulkhakova AG; Safronova VG
Cell Signal; 2014 Oct; 26(10):2138-46. PubMed ID: 24880063
[TBL] [Abstract][Full Text] [Related]
29. Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection.
Wu C; Zhao Y; Xiao X; Fan Y; Kloc M; Liu W; Ghobrial RM; Lan P; He X; Li XC
Am J Transplant; 2016 Sep; 16(9):2563-73. PubMed ID: 27575724
[TBL] [Abstract][Full Text] [Related]
30. Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways.
Zhang L; You J; Sidhu J; Tejpal N; Ganachari M; Skelton TS; Kloc M; Li XC; Ghobrial RM
Transplantation; 2013 Nov; 96(9):782-90. PubMed ID: 23985719
[TBL] [Abstract][Full Text] [Related]
31. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
Rozo C; Chinenov Y; Maharaj RK; Gupta S; Leuenberger L; Kirou KA; Bykerk VP; Goodman SM; Salmon JE; Pernis AB
Ann Rheum Dis; 2017 Apr; 76(4):740-747. PubMed ID: 28283529
[TBL] [Abstract][Full Text] [Related]
32. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M
Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of RhoA and changes in T cell cytoskeleton correlate with the abrogation of allograft rejection.
Skelton TS; Tejpal N; Gong Y; Kloc M; Ghobrial RM
Transpl Immunol; 2010 Aug; 23(4):185-93. PubMed ID: 20619345
[TBL] [Abstract][Full Text] [Related]
34. Mouse macrophage polarity and ROCK1 activity depend on RhoA and non-apoptotic Caspase 3.
Liu Y; Minze LJ; Mumma L; Li XC; Ghobrial RM; Kloc M
Exp Cell Res; 2016 Feb; 341(2):225-36. PubMed ID: 26875770
[TBL] [Abstract][Full Text] [Related]
35. Pioglitazone prevents acute and chronic cardiac allograft rejection.
Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
[TBL] [Abstract][Full Text] [Related]
36. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
37. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
[TBL] [Abstract][Full Text] [Related]
38. Low intensity pulsed ultrasound accelerates macrophage phagocytosis by a pathway that requires actin polymerization, Rho, and Src/MAPKs activity.
Zhou S; Bachem MG; Seufferlein T; Li Y; Gross HJ; Schmelz A
Cell Signal; 2008 Apr; 20(4):695-704. PubMed ID: 18207700
[TBL] [Abstract][Full Text] [Related]
39. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
40. Activation of ERM-family proteins via RhoA-ROCK signaling increases intestinal P-gp expression and leads to attenuation of oral morphine analgesia.
Kobori T; Harada S; Nakamoto K; Tokuyama S
J Pharm Sci; 2013 Mar; 102(3):1095-105. PubMed ID: 23303573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
